Inventiva (IVA) Exchange Rate Effect (2021 - 2025)

Inventiva (IVA) posted quarterly Exchange Rate Effect of $2.4 million for Q4 2022, down 28.16% year-over-year from $3.4 million in Q4 2021, and up 171.16% quarter-over-quarter from -$3.4 million in Q3 2022.

Inventiva (IVA) Exchange Rate Effect (2021 - 2025) Analysis & Trends

Inventiva's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2022.

  • In Q4 2022, Exchange Rate Effect fell 28.16% year-over-year to $2.4 million; the TTM figure through Dec 2022 stood at $10.4 million (changed N/A YoY), while the FY2025 annual figure was -$544772.4, down 141.21% from the prior year.
  • Exchange Rate Effect for Q4 2022 stood at $2.4 million, up from -$3.4 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $8.0 million in Q2 2021, with the low at -$4.4 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -300,000.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.84 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -14,590.12
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -2.45 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -287,000.00
10 Inventiva 888.89 Mn 888.89 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -842,178.01
Jun 30, 2025 -842,178.01
Dec 31, 2022 2.44 Mn
Dec 31, 2022 2.44 Mn
Sep 22, 2022 -3.43 Mn
Sep 22, 2022 -3.43 Mn
Dec 31, 2021 3.39 Mn
Dec 31, 2021 3.39 Mn
Jun 30, 2021 7.99 Mn
Jun 30, 2021 7.99 Mn
Mar 31, 2021 -4.42 Mn
Mar 31, 2021 -4.42 Mn